HOLOGIC, INC.
HOLX US4364401012
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 5% | 2% | -5% | -1% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Macmillan Stephen P CEO |
67.32 USD |
38,700 Sold |
2,605,284 USD |
22/09/2025 | 22/09/2025 |
| Macmillan Stephen P CEO |
67.04 USD |
77,418 Sold |
5,190,103 USD |
22/09/2025 | 22/09/2025 |
| Macmillan Stephen P CEO |
66.13 USD |
22,240 Sold |
1,470,731 USD |
22/09/2025 | 22/09/2025 |
| Madaus Martin D |
55.24 USD |
5,445 Bought |
300,760 USD |
07/05/2025 | 07/05/2025 |
| Madaus Martin D |
55.24 USD |
5,445 Bought |
300,760 USD |
07/05/2025 | 07/05/2025 |
| Mitchell Essex D COO |
76.34 USD |
24,856 Sold |
1,897,482 USD |
04/12/2024 | 04/12/2024 |
| Oberton Karleen Marie CFO |
80.56 USD |
52,679 Sold |
4,243,662 USD |
29/08/2024 | 29/08/2024 |
| Schnittker Brandon PR |
83.11 USD |
476 Sold |
39,559 USD |
06/08/2024 | 06/08/2024 |
| Cohn Benjamin Jordan CCO |
81.99 USD |
5,093 Sold |
417,570 USD |
01/08/2024 | 01/08/2024 |
| Macmillan Stephen P CEO |
81.44 USD |
16,177 Sold |
1,317,455 USD |
30/07/2024 | 30/07/2024 |